Gene Therapy - Table of Contents alert Volume 24 Issue 2

If you are unable to see the message below, click here to view.

Advertisement Make Gene Therapy Affordable Offering AAV, lenti and adeno vectors for pre-clinical and clinical applications Proven track record in preclinical and GMP Phase I/II clinical materials used in vaccine, cell & gene therapy applications for 13 years Perfect for meeting small-scale aseptic filling in our BSL-3 viral production area  Learn more TABLE OF CONTENTS Volume 24, Issue 2 (February 2017) In this issue Editorial News and Commentary Comment Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top 10 Years of Rare Disease Day R J Yáñez-Muñoz Gene Ther 2017 24: 67; 10.1038/gt.2017.7 Full Text News and Commentary Top Gene therapy approaches for prevention of retinal degeneration in Usher syndrome D S Williams, A Chadha, R Hazim and D Gibbs Gene Ther 2017 24: 68-71; advance online publication, January 5, 2017; 10.1038/gt.2016.81 Full Text Comment Top Do we need marker gene studies in humans to improve clinical AAV gene therapy? T Weber Gene Ther 2017 24: 72-73; advance online publication, January 5, 2017; 10.1038/gt.2016.84 Full Text Original Articles Top APOBEC3A intratumoral DNA electroporation in mice A Kostrzak, V Caval, M Escande, E Pliquet, J Thalmensi, T Bestetti, M Julithe, L Fiette, T Huet, S Wain-Hobson and P Langlade-Demoyen Gene Ther 2017 24: 74-83; advance online publication, November 18, 2016; 10.1038/gt.2016.77 Abstract | Full Text Conditional control of suicide gene expression in tumor cells with theophylline-responsive ribozyme Y Zhang, J Wang, H Cheng, Y Sun, M Liu, Z Wu and R Pei Gene Ther 2017 24: 84-91; advance online publication, November 22, 2016; 10.1038/gt.2016.78 Abstract | Full Text Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment OPEN E Eriksson, R Moreno, I Milenova, L Liljenfeldt, L C Dieterich, L Christiansson, H Karlsson, G Ullenhag, S M Mangsbo, A Dimberg, R Alemany and A Loskog Gene Ther 2017 24: 92-103; advance online publication, December 1, 2016; 10.1038/gt.2016.80 Abstract | Full Text Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice D Shin, G Lee, S Lee, S Park, K-H Jung, J H Lee, J M Lee, J-Y Kim, J Cho and H Bae Gene Ther 2017 24: 104-112; advance online publication, December 20, 2016; 10.1038/gt.2016.86 Abstract | Full Text Short Communication Top Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles D Sharma, R Al-Khalidi, S Edgar, Q An, Y Wang, C Young, D Nowis and D C Gorecki Gene Ther 2017 24: 113-119; advance online publication, December 22, 2016; 10.1038/gt.2016.82 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.